about
Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathyTransjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascitesPhase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma.Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota.
P2860
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2011
@uk
name
Management of hepatic encephalopathy
@en
Management of hepatic encephalopathy
@nl
type
label
Management of hepatic encephalopathy
@en
Management of hepatic encephalopathy
@nl
prefLabel
Management of hepatic encephalopathy
@en
Management of hepatic encephalopathy
@nl
P2093
P2860
P356
P1476
Management of hepatic encephalopathy
@en
P2093
P2860
P304
P356
10.4061/2011/841407
P407
P577
2011-01-01T00:00:00Z